Amerikanische Gesellschaft für Hirudotherapie

Sarcopenia and microvascular free flap reconstruction.

Review published in Current opinion in otolaryngology & head and neck surgery (2021)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewKlinische StudienChen et al. · Current opinion in otolaryngology & head and neck surgery, 2021

Abstract

PURPOSE OF REVIEW: This article reviews the recent literature regarding the impact of sarcopenia on microvascular free flap reconstruction outcomes. RECENT FINDINGS: Malnutrition, and consequent muscle loss, is a prevalent issue among head and neck cancer patients. However, diagnosis remains challenging due to a paucity of reliable objective measures. Traditional markers, such as albumin, have been used in the past to assess nutritional status, but cancer-related inflammation limits their predictive value. Recently, developments in the diagnosis of sarcopenia through the novel use of computed tomography (CT) cross-sectional muscle mass indices to evaluate body composition have proven effective and accessible. SUMMARY: Literature shows compelling evidence that sarcopenia is associated with higher rates of surgical complications that delay recovery and increase mortality. The use of CT imaging to quantify muscle loss offers an objective way to evaluate nutritional status, which is predictive of postoperative rates of complications. Research on ways to optimize muscle mass prior to surgery is limited, however, immunonutrition is emerging as a promising intervention that can attenuate sarcopenia-related inflammation to improve outcomes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsCross-Sectional StudiesFree Tissue FlapsHead and Neck NeoplasmsHumansPlastic Surgery ProceduresSarcopenia

Zusammenfassung

This article reviews the recent literature regarding the impact of sarcopenia on microvascular free flap reconstruction outcomes. Malnutrition, and consequent muscle loss, is a prevalent issue among head and neck cancer patients.

Warum dies für die Hirudotherapie relevant ist

This review examines how sarcopenia impacts outcomes in microvascular free flap reconstruction, noting that muscle loss is associated with higher rates of surgical complications, delayed recovery, and increased mortality. The abstract focuses on preoperative nutritional status, CT-derived muscle mass indices, and the use of immunonutrition to improve surgical outcomes. It provides no discussion of specific flap salvage techniques, anticoagulation, or complications like venous congestion. Consequently, the article does not mention leeches, the leech secretome, or hirudotherapy, and possesses no defensible clinical relevance to the American Society of Hirudotherapy.

Zitation

Sarcopenia and microvascular free flap reconstruction.

Chen et al. · Current opinion in otolaryngology & head and neck surgery, 2021

DOI

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Clinical EvidenceClinical ApplicationsMicrosurgery OutcomesSurgeryAnticoagulation CompoundsHemostasisDirect Thrombin InhibitorsOtolaryngologyDrug PipelineDrug Development

Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.